Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 850-855

  Telfer, P T ^a   Garson, J A ^b   Whitby, K ^b   Grant, P R ^b   Yardumian, A ^c   Hoffbrand, A V ^d   Wonke, B ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Hepatitis C virus; Interferon; Ribavirin; Thalassaemia

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA; TREATMENT OUTCOME;

EID: 0030771312     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2953112.x     Document Type: Article

References (23)

1. Aldouri, M.A., Wonke, B., Hoffbrand, A.V., Flynn, D.M., Laulicht, M., Fenton, L.A., Scheuer, P.J., Kibbler, C.C., Allwood, C.A., Brown, D. & Thomas, H.C. (1987) Iron state and hepatic disease in patients with thalassaemia major, treated with long-term subcutaneous desferrioxamine. Journal of Clinical Pathology, 40, 1353-1359.
2. Alter, H.J. (1995) To C or not to C: these are the questions. Blood, 85, 1681-1695.
3. Angelucci, E. (1994) Antibodies to hepatitis C virus in thalassaemia. Haematologica, 79, 353-355.
4. Braconier, J.H., Paulsen, O., Engman, K. & Widell, A. (1995) Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study. Scandinavian Journal of Infectious Diseases, 27, 325-329.
5. Brillianti, S., Garson, J., Foli, M., Whitby, K., Deaville, R., Masci, C., Miglioli, M. & Barbara, L. (1994) A pilot study of combination therapy with ribavirin plus interferon alpha for interferon alpha-resistant chronic hepatitis C. Gastroenterology, 107, 812-817.
6. Chemello, L., Bonetti, P., Cavalletto, L., Talato, F., Donadon, V., Casarin, P., Belussi, F., Frezza, M., Noventa, F., Pontisso, P., Benvegnu, L., Casarin, C., Alberti, A., and the TriVeneto Viral Hepatitis Group (1995) Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology, 22, 700-706.
7. Di Bisceglie, A.M., Shindo, M., Fong, T.-L., Fried, M.W., Swain, M.G., Bergasa, N.V. Axiotis, C.A., Waggoner, J.G., Park, Y. & Hoofnagle, J.H. (1992) A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology, 16, 649-654.
8. Donohue, S.M., Wonke, B., Hoffbrand, A.V., Reittie, J., Ganeshaguru, K., Scheuer, P., Brown, D. & Dusheiko, G. (1993) Alpha interferon in the treatment of chronic hepatitis C virus in multiply transfused patients with thalassaemia major. British Journal of Haematology, 83, 491-497.
9. Dusheiko, G.M., Khakoo, S., Soni, P. & Grellier, L. (1996) A rational approach to the management of hepatitis C infection. British Medical Journal, 312, 357-364.
10. Hayden, E. Schlepushkin, A. & Pushkarskaya, N. (1984) Combined interferon alfa-2b, rimantadine hydrochloride and ribavirin inhibition of influenza virus replication in vitro. Antimicrobial Agents and Chemotherapy, 25, 53-57.
11. Kwok, S. & Higuchi, R. (1989) Avoiding false positives with PCR. Nature, 339, 237-238.
12. Patterson, J.L. & Fernandez-Larsson, R. (1990) Molecular mechanisms of action of ribavirin. Reviews of Infectious Diseases, 12, 1139-1146.
13. Poynard, T., Bedossa, P., Chevallier, M., Mathurin, P., Lemonnier, C., Trepo, C., Couzigou, P., Payen, J.L., Sajus, M., Costa, J.M., Vidaud, M., Chaput, J.C., and The Multicentre Study Group (1995) A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. New England Journal of Medicine, 332, 1457-1462.
14. Reichard, O., Yun, Z., Sonnerborg, A. & Weiland, O. (1993) Hepatitis C viral RNA titres in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. Journal of Medical Virology, 41, 99-102.
15. Saldanha, J. & Minor, P. (1996) Collaborative study to assess the suitability of an HCV RNA reference sample for detection of HCV RNA in plasma pools by PCR. Vox Sanguinis, 70, 148-151.
16. Schvarcz, R., Yun, Z.B., Sonnerborg, A. & Weiland, O. (1995) Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. Journal of Medical Virology, 46, 43-47.
17. Shindo, M., Di Bisceglie, A.M. & Hoofnagle, J.H. (1992) Long-term follow-up of patients with chronic hepatitis C treated with alpha interferon. Hepatology, 15, 1013-1016.
18. Shulman, N.R. (1984) Assessment of hematologic effects of ribavirin in humans. Clinical Applications of Ribavirin (ed. by R. Smith and V. Knight), pp. 79-92. Academic Press, New York.
19. Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van-Heuverswyn, H. & Maertens, G. (1993) Typing of hepatitis C isolates and characterisation of new subtypes using a line probe assay. Journal of General Virology, 74, 1093-1102.
20. van Doom, L.J., Kleter, B., Pike, I. & Quint, W. (1996) Analysis of hepatitis C virus isolates by serotyping and genotyping. Journal of Clinical Microbiology, 34, 1784-1787.
21. Whitby, K. & Garson, J.A. (1995) Optimization and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA. Journal of Virological Methods, 51, 75-88.
22. Wonke, B., Hoffbrand, A.V., Brown, D. & Dusheiko, G. (1990) Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. Journal of Clinical Pathology, 43, 638-640.
23. Zurlo, M.G., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Piga, A., Melevende, C., Di Gregorio, F., Burattini, M.G. & Terzoli, S. (1989) Survival and causes of death in thalassaemia major. Lancet, ii, 27-30.